Mendoza, Rose Ann C.

HRN: 10-25-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFUROXIME 1.5GM (VIAL)
08/06/2025
08/13/2025
IVT
1.5 GMS
ON CALL TO OR THEN Q 8
LTCS
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines